Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States

During April 2009-June 2010, thirty-seven (0.5%) of 6,740 pandemic (H1N1) 2009 viruses submitted to a US surveillance system were oseltamivir resistant. Most patients with oseltamivir-resistant infections were severely immunocompromised (76%) and had received oseltamivir before specimen collection (...

Full description

Saved in:
Bibliographic Details
Published in:Emerging infectious diseases Vol. 17; no. 2; pp. 255 - 257
Main Authors: Graitcer, Samuel B, Gubareva, Larisa, Kamimoto, Laurie, Doshi, Saumil, Vandermeer, Meredith, Louie, Janice, Waters, Christine, Moore, Zack, Sleeman, Katrina, Okomo-Adhiambo, Margaret, Marshall, Steven A, St George, Kirsten, Pan, Chao Yang, LaPlante, Jennifer M, Klimov, Alexander, Fry, Alicia M
Format: Journal Article
Language:English
Published: United States U.S. National Center for Infectious Diseases 01-02-2011
Centers for Disease Control and Prevention
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:During April 2009-June 2010, thirty-seven (0.5%) of 6,740 pandemic (H1N1) 2009 viruses submitted to a US surveillance system were oseltamivir resistant. Most patients with oseltamivir-resistant infections were severely immunocompromised (76%) and had received oseltamivir before specimen collection (89%). No evidence was found for community circulation of resistant viruses; only 4 (unlinked) patients had no oseltamivir exposure.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1080-6040
1080-6059
DOI:10.3201/eid1702.101724